Clinical Updates on Juvenile Idiopathic Arthritis

Dear Colleagues,

Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disorder and encompasses a group of heterogenous inflammatory joint conditions, each having different clinical signs, symptoms and, in some cases, pathogenetic mechanisms and genetic background. JIA is a leading cause of long-term disability in childhood and it can severely affect the quality of life of patients and their families. Chronic uveitis, one of JIA extra-articular complications, can impair visual function, whereas macrophage activation syndrome, which can complicate the systemic form of JIA, is a life-threatening condition.

In the last decades, impressive improvements in JIA management and long-term outcomes have been made, owing to the constant advances in translational research, the more widespread use of intra-articular glucocorticoids and the availability of a broad spectrum of effective systemic therapies. A treat-to-target approach should be adopted to achieve remission in JIA patients. Valid and reliable outcome measures have been developed and should be used to evaluate disease activity, together with feasible patient/parent-centered assessment tools. The incorporation of imaging techniques, such as ultrasound or magnetic resonance imaging, into the evaluation of children with JIA might enforce the findings of clinical examination and lead to a better definition of the treatment response.

The purpose of this Special Issue is to unravel all these aspects by providing new evidence through original articles and highlighting up-to-date knowledge via literature reviews.

Dr. Roberta Naddei
Prof. Dr. Maria Alessio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• juvenile idiopathic arthritis
• treatment
• outcome measures
• treat-to-target
• ultrasound
• biologic agents
• intra-articular glucocorticoids
• disease activity